Accurate results
for patient care
Laboratory medicine and in vitro diagnostics

JCTLM Database: higher-order reference materials, methods and services

Details : C19RMP11 - ID-LC-MS/MS-based reference measurement procedure for the quantification of methotrexate in human serum and plasma

Type (acronym)rmp
Typereference measurement procedure
Unique Nomination NumberC19RMP11
Analyte Namemethotrexate
IUPAC IFCC NumberCAS59-05-2
Method capable of Traceability of Analyte to SI or Defined Procedureyes
Applicable Matriceshuman serum and plasma; fresh or frozen Lithium heparin plasma, K3-EDTA plasma, K2-EDTA plasma
NameID-LC-MS/MS-based reference measurement procedure for the quantification of methotrexate in human serum and plasma
Organization that developed Validated MethodLabor Berlin - Charité Vivantes Services GmbH in collaboration with Roche Diagnostics GmbH
Measurement Techniques UsedIsotope dilution mass spectrometry
QuantityMass concentration
From (0)7.2
To (0)5700
Unit (0)ng/mL
From (1)7.8
To (1)3.6
Unit (1)%
Level of Confidence (%)95%
Comments on Uncertainty RangeThe lowest expected measurement uncertainty of 7.8 % is at the mass concentration of 24.00 ng/mL. The highest expected measurement uncertainty of 3.6 % is at the mass concentration of 4200 ng/mL.
Peer Reviewed PublicationAn isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of methotrexate in human serum and plasma, Taibon J. et al, Clinical Chemisty and Laboratory Medicine 2023 61(11) 1917-1929
Comments to be published via JCTLM DBThis reference measurement procedure was developed and validated by Labor Berlin - Charité Vivantes Services GmbH in collaboration with Roche Diagnostics GmbH
Analyte Category NameDrugs
Non-CCQM Key Comparison ReportSee CCLM publication cited above for comparability assessment study
Measurement principle/techniqueIsotope dilution mass spectrometry